NARA Discovery
Article Details
← Back to Search Results
Journal Article

No effect on QT intervals of mipomersen, a 2′-O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects

Rosie Z. Yu; Rudy Gunawan; Zhaoyang Li; Robert S. Mittleman; Asif Mahmood; John S. Grundy; Walter Singleton; Richard Geary; Yanfeng Wang
European Journal of Clinical Pharmacology · Vol. 72, Issue 3 · pp. 267-275 · 2016

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Pharmacology
PublisherSpringer
Publication Date2016-03-01
Publication Year2016
Volume72
Issue3
Pages267-275
Document TypeJournal Article
Print ISSN0031-6970
eISSN1432-1041
DOI10.1007/s00228-015-1992-y

Access Information

NARA Access Coverage1968-01-01~Current
Journal Homepagehttps://www.springer.com/journal/228
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.